Premium
Possible anaphylactic reaction to abciximab
Author(s) -
Guzzo Joseph A.,
Nichols Timothy C.
Publication year - 1999
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/(sici)1522-726x(199909)48:1<71::aid-ccd14>3.0.co;2-2
Subject(s) - medicine , abciximab , epinephrine , anaphylactic reaction , anesthesia , airway obstruction , cardiology , airway , anaphylaxis , myocardial infarction , percutaneous coronary intervention , allergy , immunology
We report a patient who experienced a severe anaphylactic reaction during coronary artery stenting. Subsequent to administration of a weight‐adjusted dose of abciximab, the patient developed profound hypotension and severe, acute airway obstruction. The reaction was successfully reversed with a 16‐hr infusion of epinephrine, steroids, and an H1 blocker. Cathet. Cardiovasc. Intervent. 48:71–73, 1999. © 1999 Wiley‐Liss, Inc.